Literature DB >> 9087596

Preconditioning cultured human pediatric myocytes requires adenosine and protein kinase C.

J S Ikonomidis1, T Shirai, R D Weisel, B Derylo, V Rao, C I Whiteside, D A Mickle, R K Li.   

Abstract

We showed previously that 20 min of low-volume anoxia ("ischemia") and 20 min of "reperfusion" preconditions quiescent pediatric myocyte cultures against damage resulting from 90 min of subsequent prolonged ischemia and 30 min of reperfusion. The purpose of this study was to assess the roles of adenosine and protein kinase C (PKC) in this preconditioning model. Our results suggest that 1) preconditioned myocytes secrete a protective mediator(s) into the "ischemic" supernatant that is transferable to other cells, and adenosine is released into the supernatant in quantities sufficient for adenosine-receptor activation (2) preconditioning is inhibited by adenosine-receptor antagonism, and myocyte protection similar to preconditioning can be achieved with exogenously administered adenosine or adenosine-receptor stimulation; (3) brief ischemic and adenosine-induced myocyte preconditioning is mimicked by the phorbol ester 4beta-phorbol 12-myristate 13-acetate (PKC agonist) and inhibited by PKC antagonists; and (4) brief ischemic and adenosine-induced myocyte preconditioning both induce PKC translocation to myocyte membranes and increase the PKC phosphorylation rate. These data suggest that adenosine released from ischemic human pediatric myocytes mediates preconditioning through activation of PKC.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9087596     DOI: 10.1152/ajpheart.1997.272.3.H1220

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  7 in total

1.  Phase I to II cross-induction of xenobiotic metabolizing enzymes: a feedforward control mechanism for potential hormetic responses.

Authors:  Qiang Zhang; Jingbo Pi; Courtney G Woods; Melvin E Andersen
Journal:  Toxicol Appl Pharmacol       Date:  2009-04-14       Impact factor: 4.219

Review 2.  Adenosine receptors and reperfusion injury of the heart.

Authors:  John P Headrick; Robert D Lasley
Journal:  Handb Exp Pharmacol       Date:  2009

3.  Long-term expression of protein kinase C in adult mouse hearts improves postischemic recovery.

Authors:  R Tian; W Miao; M Spindler; M M Javadpour; R McKinney; J C Bowman; P M Buttrick; J S Ingwall
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-09       Impact factor: 11.205

4.  Inhibition by fenoterol of human eosinophil functions including beta2-adrenoceptor-independent actions.

Authors:  A Tachibana; M Kato; H Kimura; T Fujiu; M Suzuki; A Morikawa
Journal:  Clin Exp Immunol       Date:  2002-12       Impact factor: 4.330

5.  Antagonism of endogenous nociceptin/orphanin FQ inhibits infarction-associated ventricular arrhythmias via PKC-dependent mechanism in rats.

Authors:  Y Han; Z Guo; L L Wang; L Z Zhang; T P Yao
Journal:  Br J Pharmacol       Date:  2013-10       Impact factor: 8.739

6.  Synergistic effects of adenosine A1 and P2Y receptor stimulation on calcium mobilization and PKC translocation in DDT1 MF-2 cells.

Authors:  Bertil B Fredholm; Jean W Assender; Eva Irenius; Noriko Kodama; Naoaki Saito
Journal:  Cell Mol Neurobiol       Date:  2003-06       Impact factor: 5.046

7.  Sirtuin 1 Mediates Hydrogen Sulfide-induced Cytoprotection Effects in Neonatal Mouse Cardiomyocytes.

Authors:  Ai-Jun Liu; Bin Li; Ming Yang; Yang Liu; Ying-Long Liu; Jun-Wu Su
Journal:  Chin Med J (Engl)       Date:  2017-10-05       Impact factor: 2.628

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.